申请人:ARIAGEN, INC.
公开号:US20190284149A1
公开(公告)日:2019-09-19
Disclosed is an aryl hydrocarbon receptor modulator of formula (I), and a pharmaceutically acceptable salt thereof, wherein
R′ is H, CN, CH
2
(OH)R
0
, C
m
H
2m+1
, C
n
H
2n−1
, C
n
H
2n−3
,
two R
a
are independently H or two R
a
together form =
0
or ═N—W
3
—R
1
; A is a C
6
to C
10
aromatic ring unsubstituted or substituted with 1 to 3 R, or a C
2
-C
10
heteroaromatic ring interrupted by 1 to 5 heteroatoms selected from N, 0, and S or a 4 to 7 membered nonaromatic heterocyclic ring containing C═N and interrupted by 1 to 3 heteroatoms selected from N, 0, and S, with either one unsubstituted or substituted with 1 to 3 R; Q is R, or is a C
6
to C
10
aromatic ring or a C
2
to C
10
heteroaromatic ring unsubstituted or substituted with 1 to 3 R and interrupted by 1 to 5 heteroatoms selected from N, 0, and S; and R is R
C
which is C-attached or R
N
which is N-attached. The compounds of formula (I) of the present invention can regulate AhR activity, and can be used to inhibit the growth of cancer cells and inhibit the metastasis and invasion of tumor cells.